Cord blood-derived expanded allogeneic natural killer cells (MD Anderson)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameCord blood-derived expanded allogeneic natural killer cells (MD Anderson)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cell replacements
TargetsNot applicable
Therapy Area/IndicationsSkin MelanomaSolid tumoursUrologic Neoplasms +[13] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsSkin MelanomaSolid tumoursUrologic Neoplasms +[13] 

Other Information

ATC CodeN/A
Related LinksN/A